ABSTRACT: Current hypotheses
INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of death in the United
States, Europe and Japan 1 and is poised to become the most significant health problem worldwide. According to the World Health Organisation (WHO), an estimated 17 million people die of CVDs, particularly heart attack, stroke and heart failure, every year. In Mauritius deaths due to cardiovascular dysfunctions have kept on increasing for the last 10 years attaining the 51% mark in 2004 2 . Cardiovascular disease is of multifactorial etiology associated generally to a variety of risk factors for its development including hypercholesterolaemia, hypertension, smoking, diabetes, poor diet, stress and physical inactivity amongst others. During the last few decades, research data has prompted a passionate debate as to whether oxidation, or specifically, oxidative stress mediated by free radicals/reactive oxygen species (ROS)/reactive nitrogen species (RNS), is a primary or secondary cause of many chronic diseases. As a result, scientific resources have focused to a large extent on the role that antioxidants could play to delay or prevent oxidative stress and consequently the incidence of chronic disorders. This article will review the biology of ROS/RNS, their pathways through which they relate to the pathology of cardiovascular disease. We shall also discuss the roles that antioxidants may play in controlling oxidative stress and reduce the incidence of CVDs.
BASIC CONCEPTS OF FREE RADICALS, REACTIVE NITROGEN SPECIES, REACTIVE OXYGEN SPECIES AND OXIDATIVE STRESS:
A free radical is any chemical species (capable of independent existence) possessing one or more unpaired electrons, an unpaired electron being one that is alone in an atomic or molecular orbital. Free radicals are formed from molecules via the breakage of a chemical bond such that each fragment keeps one electron (free radicals may also be formed by collision of the non radical species by a reaction between a radical and a molecule -which must then result in a radical since the total number of electrons is odd), by cleavage of a radical to give another radical and, finally via redox reactions 3 ) are not free radicals but can easily lead to free radical reactions in living organisms. The term 'reactive oxygen species' (ROS) and 'reactive nitrogen species' (RNS) is a collective term that includes not only the radicals but also the non-radicals. Oxidative stress is the term referring to the imbalance between generation of reactive oxygen species and the activity of the antioxidant defences. Humans and other aerobes are able to tolerate oxygen (O 2 ) because, at the same time that organisms were evolving electron-transport chains and other enzyme systems to utilize this molecule, antioxidant defenses to protect against the toxic effects of O 2 were evolving in parallel. The aerobic life-style offers great advantages, but is fraught with danger. ROS/RNS are constantly generated in vivo via two main types of processes. ROS/RNS can arise from accidental generation; this encompasses such mechanisms as 'leakage' of electrons onto O 2 from mitochondrial electron transport chains; nuclear membrane, endoplasmic reticulum (xenobiotic metabolism, prostaglandin synthesis) and hepatocytes (detoxification) contain electron transport systems, cytochrome P-450 and b 5 . has been implicated in adult respiratory distress syndrome, septic shock, hypertension, thrombosis, renal failure, AIDS encephalopathy, bronchospasm, stroke and male impotence 22 .
Table 1 Chemical Reactions of Free Radicals* Unimolecular Radical Reactions
Reactions result from the instability of the first formed radical. The radicals may completely decompose or rearrange before reaction with other molecules or radicals present. Decomposition: reaction in which the radical decomposes to give a stable molecule and a new radical Rearrangement:
1. breaking of an adjacent C-C bond in a cyclic system with concomitant formation of a new bond, usually carbonyl and a new isomeric radical 2. migration of an atom, via intramolecular abstraction by the radical center, thus creating a new, isomeric radical.
Radical-Molecule Interactions
Addition to unsaturated systems: 1. Addition of a radical to an olefinic double bond to give a new saturated, radical. Typical reaction is the radical induced polymerization of olefins. 2. Addition of a radical to an aromatic double bond. This intermediate step is widespread in free radical chemistry, e.g. in the radical substitution of aromatic compounds (homolytic aromatic substitution). The net overall reaction is displacement of an aromatic substituent by a radical: 
Abstraction or displacement: S H 2 reactions

Radical-Radical Interactions
Dimerization or radical coupling Localized radicals (methyl, phenyl radicals) react readily with little chance of dimerization. Only delocalized radicals have a high probability of dimerization in solution. Thus,
When R' = R", the reaction is dimerization and when R' ≠ R" the reaction is radical coupling or combination.
Radical disproportionation
Involves collision of the radicals resulting in the abstraction of an atom, usually hydrogen, by one radical from the other. This leads to the formation of two stable molecules, with the atom abstracted being β to the radical center: ‡ e.g. the disproportionation of two phenylethyl radicals to give styrene and ethylbenzene. * The reader is referred to Moad and Solomon [5] for an extensive overview of the reaction sequences highlighted in this table and an examination of the complex chemistry of organic radicals. † S H 2 stands for substitution homolytic biomolecular. ‡ The disproportionation reaction derives its driving force from the formation of two newstrong bonds and from the fact that the β-CH bonds in radicals are usually weak. 
REACTIVE OXYGEN SPECIES AND THE CARDIOVASCULAR SYSTEM:
Reactive oxygen species have been considered deleterious to cell function and there is good evidence to suggest that they play a role in the pathophysiology of cardiac disease states. However, direct cause and effect relationships have not been clearly delineated. The increase in the generation of ROS under several pathophysiological conditions, that seem to be related to inflammatory processes, is still to be comprehensively understood; this may be due to difficulties in defining their site of origin. Impaired mitochondrial reduction of molecular oxygen may be an intracellular source. Secretions by phagocytic white blood cells, dysfunctional endothelial cells, or the autooxidation of catecholamines may be the extracellular sources. ROS may also result from cellular injury due to exposure to ionizing radiation, ultraviolet rays, cigarette smoking or other air pollutants. Besides their deleterious effects, ROS are also now being recognized as important regulators of cell function and modulators of cell signalling pathways.
ROS in pathophysiology of Heart disease:
One of the strategies used to assess the role of oxidative stress in the pathogenesis of cardiac dysfunction has been to expose isolated cardiac tissues to a defined oxidation stress condition and study the resulting effects
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. Further in vivo and ex vivo studies have provided precious evidence supporting the role of oxidative stress in a number of conditions (atherosclerosis, ischemia-reperfusion injury, hypertension, catecholamine-induced cardiomyopathy, diabetic cardiomyopathy, cardiac hypertrophy and congestive heart failure etc...) leading to severe cardiovascular dysfunctions. In this review the role of ROS in atherosclerosis is being emphasized as, besides being considered as the major cause of morbidity and mortality 32 its outcome is also linked to other conditions leading to cardiovascular disorders. The role of ROS in other above-mentioned conditions has been extensively reviewed and the reader is referred to a number of excellent reports 33, 34 . Most cardiovascular events are secondary to atherosclerosis, a disease of the arteries involving a local thickening of the vessel wall. A stroke or myocardial infarction occurs when the lumen of the vessel becomes completely occluded, usually by a thrombus forming at the site of a plaque. Atherosclerotic lesions are thought to be initiated by emigration of monocytes into the arterial inner core (tunica intima), recruited by adhesion molecules, possibly in response to arterial endothelium injury 35 . A variety of factors have been implicated in causing this initial injury, including mechanical damage from flow stress worsened by high blood pressure, viral infection (herpes viruses and cytomegalovirus), exposure to bloodborne toxins such as xenobiotics from cigarette smoke and elevated levels of normal metabolites, such as glucose, homocysteine or cholesterol 36 . Although a high level of plasma cholesterol is considered to trigger atherosclerosis, the oxidation of cholesterol seems to be a necessary step. In fact, uptake of oxidized low-density lipoprotein ( ox LDL) was shown to be an early event leading to the development of atherosclerosis (Figure 2) In the atherosclerotic lesion produced in the rabbit aorta, significant increases in the iron content were observed suggesting that ironcatalysed free radical reactions may be associated with the development of atherosclerosis 40 . The occurrence of intracellular Ca 2+ -overload has been proposed as a mechanism of injury due to oxidative stress because human endothelial cells subjected to oxidative stress showed an increase in the level of intracellular Ca 2+ and plasma membrane blebbing 41 . Endothelial dysfunction may play an important role in the atherosclerotic process because in patients with atherosclerosis, the antioxidants, probucol and ascorbic acid, improved the endothelium-dependent relaxation suggesting the involvement of ROS in endothelial dysfunction 42 . Increased production of O 2
•-has been implicated in the impaired endothelium-dependent relaxation in cholesterol fed rabbits and was suggested to be an early event in the hypercholesterolemic atherosclerotic process
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. 
ROS in Mediated Signal Transduction Pathways in Cardiovascular disorders:
The cardiovascular system is a highly complex, well organised system in which signal transduction plays critical physiological and pathophysiological roles (Figure 3) . The cellular elements of the heart and vascular wall are equipped with an array of specific receptors and with complex intracellular machinery that facilitates and drives appropriate responses to extracellular stimuli. All vascular cell types, including endothelial cells, smooth muscle cells, adventitial fibroblasts, and resident macrophages, produce ROS [51] [52] [53] [54] [55] . Of particular importance in the vasculature are superoxide (O 2 .-) and hydrogen peroxide (H 2 O 2 ), since these ROS act as inter-and intra-cellular signaling molecules. The major source of ROS in the vascular wall is non-phagocytic NADPH oxidase, which is regulated by vasoactive agents (Ang II, ET-1, thrombin, serotonin), cytokines (IL-1, TNFa), growth factors (PDGF, IGF-1, VEGF) and mechanical forces (cyclic stretch, laminar and oscillatory shear stress). High levels of low-density lipoprotein (LDL), especially in the form of oxidized low-density lipoprotein (ox-LDL), have also been shown to increase intracellular ROS generation. Under physiological conditions, vascular production of ROS and the consequent activation of redoxdependent signaling pathways and induction of redox-sensitive genes are tightly regulated. However, in pathological conditions, such as in hypertension, atherosclerosis, hyperlipidemia, hyperhomo-cysteinemia, and diabetes, where generation of ROS is increased and the renin angiotensin system may be upregulated, these redox-sensitive events may contribute to cellular processes involved in vascular dysfunction and structural remodeling [56] [57] [58] . Redox signalling has been suggested in vascular smooth muscle proliferation, atherosclerosis, angiogenesis, cardiac hypertrophy, fibrosis 59 . Modulation of intracellular signaling pathways (MAPKs), and the subsequent activation of downstream redox sensitive transcription factors like NF-κB, HIF-1, AP-1 results in alterations in gene and protein expression 60 that significantly enhance cardiac dysfunction. Increased bioavailability of vascular ROS leads to VSMC growth, migration, collagen deposition, and altered MMP activity, important factors in arterial remodeling in cardiovascular disease [56] [57] [58] . In endothelial cells, oxidative excess induces apoptosis and aniokis (cell shedding), leading to endothelial cell loss and resultant impaired endothelial function. In addition, oxidative stress stimulates activation of transcription factors (e.g., NFkB and AP-1) and pro-inflammatory genes (cytokines, interleukins), upregulation of adhesion molecules (e.g., ICAM, VCAM, PECAM), stimulation of chemokine production (e.g., MCP-1) and recruitment of inflammatory cells (monocytes, macrophages), critical processes involved in vascular inflammation and injury 61 by using it to oxidize reduced glutathione (GSH) to oxidized glutathione (GSSG). Glutathione reductase, a flavoprotein enzyme, regenerates GSH from GSSG, with NADPH as a source of reducing power (Figure 3) . Glutathione peroxidase also catalyse the reduction of unstable hydroperoxides at the expense of GSH 62 . The increase ROS which is produced from NSDPH oxidase may modify the activity of tyrosine kinases, such as Src, Ras, JAK2, Pyk2, PI3K, and EGFR, as well as mitogen-activated protein kinases (MAPK), particularly p38MAPK, JNK and ERK5. ROS may inhibit protein tyrosine phosphatase activity, further contributing to protein tyrosine kinase activation. ROS also influence gene and protein expression by activating transcription factors, such as NF B activator protein-1 (AP-1) and hypoxia-inducible factor-1 (HIF-1). ROS stimulate ion channels, such as plasma membrane Ca 2+ and K + channels, leading to changes in cation concentration. Activation of these redox-sensitive pathways results in numerous cellular responses which, if uncontrolled, could contribute to hypertensive vascular damage.
ROS
The second line of defence is represented by radical scavenging antioxidants such as vitamin C, vitamin A and plant phytochemicals like phenolics (emphasised later in this review) that inhibit the oxidation chain initiation and prevent chain propagation
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. This may also include the termination of a chain by the reaction of two radicals. The repair and de novo enzymes act as the third line of defense by repairing damage and reconstituting membranes. These include lipases, proteases, DNA repair enzymes and transferases 64 . A number of studies have been conducted to explore the roles of various antioxidants in cardiovascular diseases. Diphenylene iodonium (DPI), a potent inhibitor of NADH/NADPH oxidase enzyme has been shown to suppress p38 MAP kinase-mediated VSMC hypertrophy in vitro 65 . Furthermore, it was reported that Nacetyl-L-cysteine (NAC), a radical scavenger and intracellular glutathione precursor, inhibited endothelin-induced ROS generation, JNK activation and VSMC proliferation 66 . Probucol is a modestly potent LDL-lowering agent with powerful anti-oxidant properties that effectively inhibits the oxidative modification of LDL, independent of its lipidlowering effect. By exerting anti-oxidant effect, it may inhibit VCAM-1 and MCP-1 expression and inhibit human aortic SMC proliferation as well as atherogenesis 67 . The HMG-CoA reductase inhibitors, also known as statins, are potent lipid-modifying agents. There is overwhelming evidence from clinical studies that reducing plasma LDL levels with statins, results in a markedly lower risk of cardiovascular events related to atherosclerosis
68
. Recent studies in patients with established CAD show that these agents can cause a modest regression of atherosclerotic lesions. It has been suggested that the antiatherosclerotic effect of statins may be independent of their LDLlowering effect
69,70
. AT1R blockers and ACE inhibitors are widely used to treat patients with hypertension and/or congestive heart failure by blocking the effect of Ang II or its formation. Recent studies show that Ang II is also a strong stimulus for ROS generation 71-73 and AT1R blockers as well as ACE inhibitors inhibit the expression of proatherogenic factors by decreasing ROS production in vascular endothelial cells and in animal models [74] [75] [76] [77] . A large number of studies have provided direct evidence showing the antiatherosclerotic effects of these agents
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. Statins and AT1R blockers exert synergistic effects on the inhibition of atherosclerotic lesions in the apo E-knockout mice placed on a high cholesterol diet 81 . PPAR-γ ligands, which are widely used in the treatment of type II diabetes, have been identified as potent antioxidants
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. By suppressing NADPH oxidase expression and reducing intracellular ROS production, these agents inhibit the expression of several proatherogenic proteins and apoptosis in vascular endothelial cells and SMCs
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. Experimental studies show that thiazolidinedione, a potent PPAR-γ ligand, reduces the size and number of atherosclerotic lesions in the vessel wall by modulating foam cell formation and inflammatory responses of macrophages
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. Vitamins E and C have been demonstrated to reduce the progression of atherosclerosis. Trolox C, a water-soluble vitamin E analogue, and vitamin C (ascorbic acid) abolished the stimulatory effect of Ang II on JNK and p38 activity in VSMC 86 . Intake of vitamin E decreased the incidence of cardiovascular events in the population of ischemic heart disease patients in the Cambridge Heart Antioxidant Study (CHAOS)
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. Clinical studies show that while these anti-oxidant vitamins do not reduce endpoints related to atherosclerosis, they improve endothelial function by increasing local NO bioavailability and, therefore, endotheliumdependent vasodilation. It has been reported that high dose of vitamin C infusions improved endothelial dysfunction in patients with renovascular hypertension 88 . However, a GISSI-3 study 89 and HOPE study 90 could not show significant beneficial effects of vitamin E in the secondary prevention of coronary artery disease. A Heart Protection Study (HPS) in the UK also could not demonstrate any benefits of vitamin E, vitamin C, and β-carotene combined antioxidants therapy in a large number of high-risk people
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. There is increasing interest in phenolics stemming from the context of the "French paradox"
92 . This paradox refers to the correlation of a high-fat and high-cholesterol diet with a lower incidence of coronary heart disease found in Mediterranean cultures and contrasted with a higher incidence of coronary heart disease among most Western cultures. It has been shown that the French paradox may be attributable to regular consumption of red wine and that the unique antiatherogenic effects of red wine reside in the action of polyphenols. Phenolic compounds or polyphenols constitute one of the most numerous and ubiquitously distributed group of plant secondary metabolites, with more than 8000 phenolic structures currently known. Natural polyphenols can range from simple molecules (quinones, phenolic acids,) to highly polymerised compounds (lignins, melanins, tannins), with flavonoids such as flavonols, flavones, isoflavones, flavonones, flavanols and anthocyanins representing the most common and widely distributed sub-group 93 (Table 2) . Phenolics are therefore an integral part of the diet, with significant amounts being reported in vegetables, fruits, teas and traditional plants [94] [95] [96] [97] . Although the dietary intake of phenolics varies considerably among geographic regions, it is estimated that daily intake range from about 20 mg to 1 g, which is higher than that for Vitamin E 98 . Epidemiological evidence indicates that consumption of fruit, vegetables and teas may reduce the risk of cardiovascular disease and it is increasingly suggested that this may due to their antioxidants that include ß-carotene, vitamin C, vitamin E and polyphenolics. Dietary antioxidant phenolics may quench reactive oxygen and nitrogen species and, hence potentially modify pathogenic mechanisms relevant to cardiovascular disease. The effectiveness of a dietary antioxidant will depend on a number of factors, such as which ROS or RNS is being scavenged, how and where they are being generated and the accessibility of the antioxidant to possible sites of damage
99
. Many phenolic compounds have been shown to have antioxidant activity in vitro 100 and several observational studies support their role in potentially protecting against cardiovascular disease
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. However, not all epidemiological studies have found a protective effect of dietary phenolics against heart disease 102, 103 . In vitro studies have used various systems to oxidize LDL and then measure prevention of oxidation after inclusion of phenolic compounds like cinnamic acids
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. A range of other compounds such as ellagic acid, dimethydiisoeugenol, phenolic rich extracts derived from olive oil, wine, grape, apple and blackcurrent juices have been shown to act as potent antioxidants inhibiting LDL oxidation Ex vivo and/or increasing plasma antioxidant capacity 99 .Tea polyphenols have the inherent capacity to inhibit the development of atherosclerotic lesions by down-regulating genes controlling lipid metabolism, cytokine production and cellular activity within the arterial wall namely genes coding for PPAR-γ, CD36, LXR-α, C-myc coupled with the upregulation of genes coding for LDL-R and PPAR-α at the transcriptional level 105 . Grape seed proanthocyanidin extract (GSPE), a mixture of 75-80% oligomeric proanthocyanidin and 3-5% monomeric proanthocyanidin has proved its efficacy against the incidence of ischemiareperfusion injury, apoptosis of cardiomyocytes and reduction of foam cell development. The mechanistic pathways of cardioprotection exerted by the proanthocyanidin rich extract included (1) potent hydroxyl and other free radical scavenging abilities; (2) antiapoptotic,anti-necrotic and anti-endonucleolytic potentials; (3) modulatory effect on apoptotic regulatory bcl-X L , p53 and c-myc genes; (4) cytochrome P450 2E1 inhibitory activity; (5) inhibitory effects on proapoptotic, cardioregulatory genes c-JUN and JNK-1 and (6) inhibition of vasoconstriction of vascular smooth muscle and endothelium 106, 107 .
CONCLUSION:
The implication of oxidative stress in the etiology of several chronic and acute degenerative disorders suggests that antioxidant therapy represents a promising avenue for treatment. Strategies for the intervention and prevention of cardiovascular disease require an understanding of the basic molecular mechanism (s) by prophylactic agents (synthetic antioxidants, dietary antioxidant factors from food plants and medicinal plants) that may potentially prevent or reverse the promotion or progression of the disease. It remains unequivocal that emerging scientific support for health claims and identification of active functional ingredients needs to be balanced by addressing toxicological concerns 108 . The real proof of efficacy for existing or novel compounds/extracts should emanate from a demonstration of clinical efficacy on defined therapeutic categories 109 . In this respect, the outcome of one such trial conducted on the Mauritian population on the effects of Mauritian black tea on markers of oxidative stress leading to cardiovascular disease is currently much awaited.
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